BackPrince Pharmaceutical , Ltd. Overview

Prince Pharmaceutical , Ltd. Other Current Liabilities

Track Prince Pharmaceutical , Ltd.'s other current liabilities ($100M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$101.70M
↑ 78.60% YoYΔ $44.76M vs prior year quarter

Peer trimmed avg / median

Loading

Prince Pharmaceutical , Ltd. Other Current Liabilities History

Loading

Prince Pharmaceutical , Ltd. vs. peers: Other Current Liabilities Comparison

Loading

Prince Pharmaceutical , Ltd. Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Prince Pharmaceutical , Ltd. (6935.TWO) FAQ

The latest other current liabilities for 6935.TWO is $100M as of June 2026. That compares with $57M in the prior-year period — up 78.6% year over year. Investors often review this figure alongside Prince Pharmaceutical , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 6935.TWO's other current liabilities moved from $57M to $100M — a 78.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Prince Pharmaceutical , Ltd.'s operating scale or balance-sheet position.

A other current liabilities figure of $100M for 6935.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 6935.TWO's other current liabilities ($100M), review year-over-year change from $57M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.